Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | STAT6 | P42226 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MTOR | P42345 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | APLNR | P35414 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13490845 | 1.00 | FFAR3 (0.65) | FFAR3MAPK1TP53NFKB1CYP2C19 | |
| SCHEMBL405480 | 1.00 | FFAR3 (0.65) | FFAR3MAPK1TP53NFKB1CYP2C19 | |
| SCHEMBL14012097 | 1.00 | FFAR3 (0.65) | FFAR3MAPK1TP53NFKB1CYP2C19 | |
| SCHEMBL4442780 | 1.00 | FFAR3 (0.65) | FFAR3MAPK1TP53NFKB1CYP2C19 | |
| SCHEMBL13315169 | 0.88 | FFAR3 (0.52) | FFAR3MAPK1TP53NFKB1CYP2C19 | |
| SCHEMBL17893189 | 0.87 | FFAR3 (0.77) | FFAR3MAPK1TP53NFKB1CYP2C19 | |
| SCHEMBL17893191 | 0.87 | FFAR3 (0.77) | FFAR3MAPK1TP53NFKB1CYP2C19 | |
| SCHEMBL17893188 | 0.87 | FFAR3 (0.77) | FFAR3MAPK1TP53NFKB1CYP2C19 | |
| SCHEMBL26409341 | 0.87 | FFAR3 (0.58) | FFAR3MAPK1TP53NFKB1CYP2C19 | |
| SCHEMBL16983813 | 0.86 | FFAR3 (0.50) | FFAR3MAPK1TP53NFKB1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110088167-B | Glycolic acid polymers | 索尔维公司 | 2022-02-08 | — | — | CN | disclosed |
| US-9278909-B2 | Amide-extended crosslinking compounds and methods for use thereof | DESIGNER MOLECULES, INC. (US) | 2016-03-08 | — | — | US | disclosed |
| US-20140147794-A1 | METHOD OF FORMING PHOTORESIST PATTERN | JSR CORPORATION (JP) | 2014-05-29 | — | — | US | disclosed |
| US-8637611-B2 | Amide-extended crosslinking compounds and methods for use thereof | DESIGNER MOLECULES, INC. (US) | 2014-01-28 | — | — | US | disclosed |
| US-20130338313-A1 | AMIDE-EXTENDED CROSSLINKING COMPOUNDS AND METHODS FOR USE THEREOF | DESIGNER MOLECULES, INC. (US) | 2013-12-19 | — | — | US | disclosed |
| US-20130203895-A1 | CURING AGENTS FOR EPOXY RESINS | DESIGNER MOLECULES, INC. (US) | 2013-08-08 | — | — | US | disclosed |
| US-20130199724-A1 | CURATIVES FOR EPOXY COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2013-08-08 | — | — | US | disclosed |
| US-8435718-B2 | Upper layer-forming composition and photoresist patterning method | JSR CORPORATION (JP) | 2013-05-07 | — | — | US | disclosed |
| US-20130012620-A1 | CURING AGENTS FOR EPOXY RESINS | DESIGNER MOLECULES, INC. (US) | 2013-01-10 | — | — | US | disclosed |
| US-8288591-B2 | Curing agents for epoxy resins | DESIGNER MOLECULES, INC. (US) | 2012-10-16 | — | — | US | disclosed |
| EP-0897943-B1 | Composite resin composition | MITSUI CHEMICALS INC (JP) | 2005-05-04 | — | — | EP | disclosed |
| EP-1148075-B1 | PROCESS FOR PRODUCING ALIPHATIC POLYESTER WITH EXCELLENT STABILITY | MITSUI CHEMICALS INC (JP) | 2004-05-19 | — | — | EP | disclosed |
| US-6667194-B1 | Method of bonding die chip with underfill fluxing composition | HENKEL LOCTITE CORPORATION | 2003-12-23 | — | — | US | disclosed |
| US-20030035917-A1 | Image making medium | HYMAN SYDNEY (US) | 2003-02-20 | — | — | US | disclosed |
| EP-1148075-A1 | PROCESS FOR PRODUCING ALIPHATIC POLYESTER WITH EXCELLENT STABILITY | Mitsui Chemicals, Inc. (JP) | 2001-10-24 | — | — | EP | disclosed |
| US-6150438-A | HEATING AND REACTING AN ALIPHATIC POLYESTER RESIN WITH HYDROXYCARBOXYLIC ACID UNITS AND UNSATURATED CARBOXYLIC ACID TO FORM A MODIFIED ALIPHATIC POLYESTER, KNEADING AND BONDING WITH A BIOMASS SELECTED FROM CELLULOSE, LIGNOCELLULOSE | MITSUI CHEMICALS, INC. (JP) | 2000-11-21 | — | — | US | disclosed |
| US-6140458-A | STARTING MATERIAL IS AN EASILY-AVAILABLE, LOW-MOLECULAR ALIPHATIC POLYESTER PREPOLYMER TO BE PREPARED THROUGH POLYCONDENSATION OF INEXPENSIVE MATERIALS OF AN ALIPHATIC HYDROXYCARBOXYLIC ACID; HIGH MOLECULAR WEIGHT | MITSUI CHEMICALS, INC. (JP) | 2000-10-31 | — | — | US | disclosed |
| US-6124384-A | Composite resin composition | MITSUI CHEMICALS, INC. (JP) | 2000-09-26 | — | — | US | disclosed |
| EP-0953589-A2 | Process for preparing aliphatic hydroxycarboxylic acid polyesters | Mitsui Chemicals, Inc. (JP) | 1999-11-03 | — | — | EP | disclosed |
| EP-0897943-A2 | Composite resin composition | Mitsui Chemicals, Inc. (JP) | 1999-02-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130012620-A1 | CURING AGENTS FOR EPOXY RESINS | DOT1L, EHMT1, ASH1L | FFAR3 1230/4885MAPK1 3452/4885TP53 2583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.